SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is facing significant downward pressure as investors react to a combination of disappointing quarterly delivery figures, J.P. Morgans analyst downgrade citing major downside risk, and growing community speculation that capital is rotating out of the stock in anticipation of the upcoming SpaceX IPO. Amidst a volatile geopolitical climate, discussions on the platform are dominated by debates over leadership, the company's long-term competitive moat in the EV and AI space, and highly active trading around the stock's technical support levels.

Enovix Corp. engages in the design and development of silicon-anode lithium-ion batteries. The firm's proprietary 3D cell architecture increases energy density and maintains a high cycle life. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable utilization of renewable energy. The company was founded by Mr. Harrold Jones Rust, III, Ashok Lahiri, and Murali Ramasubramanian in November 2006 and is headquartered in Fremont, CA.

Enovix Corporation

Enovix Corp

Enovix is currently trending as investors debate the company's ability to overcome manufacturing hurdles at its Malaysia facility, specifically relating to laser dicing and production yields. While the community remains polarized between those viewing the stock as a distressed 'zombie' play and long-term believers citing institutional ownership and potential partnerships, high short interest and anticipation of upcoming purchase orders keep sentiment highly volatile.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

Fubo is facing intense debate as investors weigh the company's long-term financial guidance against a sharp price decline following a recent reverse stock split. The community remains deeply polarized, with some bulls pointing to sports-streaming dominance as a reason to hold, while skeptical traders focus on persistent bearish momentum and management's silence as catalysts for further short-selling.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

Aehr Test Systems is surging as investors cheer the company's strategic pivot into AI infrastructure and recent high-profile production orders for its ultra-high-power testing systems. The community is heavily focused on the company's role as a critical bottleneck gatekeeper for reliability in the hyperscale data center supply chain, fueling bullish sentiment around upcoming earnings and guidance.

“Buttcoin - The Next Bitcoin” is the memecoin version of Bitcoin. Launched on January 30, 2025, on Pump.fun, it’s a community-owned memecoin on Solana. The idea was inspired by a 4:20 minutes long YouTube video from 2013 called "The Next Bitcoin?" by James D. McMurray.

Buttcoin

Buttcoin is gaining attention as a long-standing meme project, with the community actively debating whether its 15-year history of mocking the crypto industry translates into lasting value or a satirical phenomenon. Supporters are pushing the asset as a nostalgic, culture-driven alternative to mainstream tokens, while others view the surrounding social media fervor as a cautionary example of speculative retail behavior.

Direxion Shares ETF Trust - Direxion Daily TSLA Bull 2X ETF

Direxion Daily TSLA Bull 2X Shares

TSLL is drawing heavy trader interest as the community debates whether recent volatility and price action represent a durable support level or a setup for further downside. Investors are actively discussing the impact of leverage decay, institutional algorithmic manipulation, and conflicting sentiment regarding the long-term viability of high-growth technology promises.

iShares Bitcoin Trust ETF (The) - iShares Bitcoin Trust Beneficial Interest

iShares Bitcoin ETF

IBIT is trending as institutional investors and whales navigate heightened volatility, with intense community debate over recent ETF accumulation patterns, broader macro pressures, and the potential impact of ongoing market manipulation allegations. The stock remains a focal point for both bulls eyeing long-term adoption and bears focused on short-term price weakness and systemic risks.

Himax Technologies, Inc. is a semiconductor solution provider dedicated to display imaging processing technologies. It operates through the Driver Integrated Circuit and Non-Driver Products segments. The company's products include display drivers, timing controllers, wafer level optics, video and display technology solutions, liquid crystal over silicon silicon, complementary metal-oxide semiconductor image sensor, and power integrated circuit. Its products used in TVs, laptops, monitors, mobile phones, tablets, digital cameras, car navigation, virtual reality (VR) devices and many other consumer electronics devices. Himax Technologies was founded by Biing Seng Wu and Jordan Wu on June 12, 2001 and is headquartered in Tainan, Taiwan.

Himax Technologies - ADR

Himax Technologies, Inc.

Himax Technologies is trending as investors actively debate its long-term potential as a supplier for the Co-Packaged Optics (CPO) market, with community discussions focused on its strategic integration into next-generation AI data center roadmaps. While shareholders remain divided over the company's historical management performance, recent news cycles highlighting its role in emerging optical component supply chains have reignited interest in its growth prospects.

Enphase Energy, Inc. is a global energy technology company, which engages in the business of designing, developing, manufacturing, and selling home energy solutions that manage energy generation, energy storage, control, and communications on one intelligent platform. It operates through the following geographical segments: the United States, the Netherlands, and Others. The company was founded by Raghuveer R. Belur and Martin Fornage in March 2006 and is headquartered in Fremont, CA.

Enphase Energy Inc

Enphase Energy is experiencing significant volatility as investors weigh a strong quarterly earnings beat and positive guidance against broader solar sector headwinds and concerns over upcoming debt obligations. The community remains deeply polarized, with some bulls highlighting the long-term potential of residential solar and battery storage in an AI-driven energy economy, while others express frustration over the stock's persistent downtrend, regulatory uncertainty, and aggressive short-selling activity.

Soleno Therapeutics, Inc. operates as clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. It focuses on the treatment of metabolic and neurobehavioral disorder. It offers its lead candidate, Diazoxide Choline Controlled-Release (DCCR), an oral tablet for the treatment of Prader-Willi Syndrome (PWS). The company was founded on August 25, 1999 and is headquartered in Redwood City, CA.

Soleno Therapeutics Inc

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Catheter Precision had initially acquired a 20% stake in Flyte in February before buying out the remaining 80% earlier on Tuesday.</li><li>Creatd will receive around $6 million in cash and roughly $6 million in convertible preferred stock of VTAK, making it a significant shareholder.</li><li>Earlier this month, Catheter Precision signed an agreement to raise about $1.9 million through a private placement.</li></ul>Shares of Catheter Precision (VTAK) jumped 50% on Tuesday after the company announced it had completed the acquisition of Fly Flyte, having bought out an 80% stake from Creatd.Flyte runs regional aviation services using Cirrus Vision Jets on short-haul routes where commercial airline service is limited or unavailable. It generates revenue through aircraft equipped with advanced safety systems such as whole-aircraft parachute technology and Safe Return autonomous landing capability.<h2 class="st-heading-2">Creatd To Receive $6M In Cash, $6M In Convertible Preferred Stock</h2>As part of the transaction, Creatd will receive around $6 million in cash and roughly $6 million in convertible preferred stock of VTAK. The two companies will collaborate on developing an aviation and Electric Vertical Take-Off and Landing (eVTOL) logistics platform.The deal makes Creatd a significant shareholder in VTAK, while it continues to pursue its plan to secure a national exchange listing later this year.Catheter Precision had initially acquired a 20% stake in Flyte in February, stating that the investment provides immediate exposure to the fast-growing private aviation sector and supports an asset-backed, scalable fleet expansion model.<h2 class="st-heading-2">Fundraising Worth Around $1.9 Million</h2>Earlier this month, Catheter Precision signed a securities purchase agreement with investors to raise about $1.9 million through a private placement of Series C-1 Convertible Preferred Stock, according to an SEC filing. The shares can initially convert into up to 1.3 million common shares at a conversion price of $1.43 per share.Investors also agreed to purchase additional Series C-2 and Series C-3 convertible preferred shares. The company plans to use the proceeds for working capital, restructuring its legacy catheter business, resolving liabilities, and reducing operating expenses.This came after the company completed a strategic financing deal with institutional investors worth up to $36.5 million last month.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment for <a href="https://stocktwits.com/symbol/VTAK">VTAK</a> on Stocktwits flipped to ‘extremely bullish’ from ‘bearish’ a day earlier, amid ‘extremely high’ message volumes.<img src="https://news.stocktwits-cdn.com/VTAK_jpg_6ed250b1a0.webp" alt="VTAK.jpg">One user expects the momentum to push the stock to $3 from its current price of around $2.<stembedurl>https://stocktwits.com/LosersMakeMillions/message/647117481</stembedurl>Another user said that since the revenue is “asset-backed,” it will grow when new jets are added to the service.<stembedurl>https://stocktwits.com/bachsong/message/647102061</stembedurl>VTAK shares have gained around 10% so far this year.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/polymarket-pltr-stock-palantir-crackdown-insider-trading-sports-betting/cZdopaXRI7R">Polymarket Ropes In Palantir To Track Suspicious Sports Prediction Bets: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A candlestick chart can be seen in a trading platform on a smartphone. Top U.S. firms announced record buybacks this year. (Photo by Silas Stein/picture alliance via Getty Images)

This Nano-Cap Medical Device Stock Soared 50% Today – What’s The Aviation Connection?

Catheter Precision completed the acquisition of Fly Flyte from Creatd, giving it access to the fast-growing private aviation sector.

VTAK Stock Jumps 50% Today – What’s Driving The Super Rally?

Equity

Strategic Partnerships and Platform Plays Power New Momentum Across Tech and Healthcare

Markets open the session with strategic partnerships, infrastructure consolidation, and breakthrough technologies dominating the corporate news cycle; several companies are positioning themselves at the intersection of innovation and scalable commercialization. $INKT, $VTAK, $KBLB, $APP, $BEAT, $SGN, $STGW

Medical device company Catheter Precision, Inc. (VTAK) announced on Monday that it has received approval for its suture retention device LockeT in the United Kingdom.LockeT is intended to assist in wound closure after percutaneous venous punctures or procedures involving the insertion of a needle through the skin to access the vein, including for the insertion of catheters. LockeT <a target="_blank" rel="noopener noreferrer nofollow" href="https://feeds.issuerdirect.com/news-release.html?newsid=4827478167656712&amp;symbol=VTAK">received</a> CE Mark for European approval and distribution in May 2025, but had to obtain registration to launch sales in the U.K. CE marking indicates a product's compliance with European Union (EU) safety, health, and environmental protection standards, allowing it to be sold freely within the European Economic Area (EEA).On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/VTAK">Catheter Precision</a> jumped from ‘bullish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘low’ to ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:627/58;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_18_at_12_40_56_PM_png_d31ad45d5e.webp" alt="VTAK's Sentiment Meter and Message Volume as of 12:40 p.m. ET on Aug. 18, 2025 | Source: Stocktwits" width="627" height="58"><figcaption>VTAK's Sentiment Meter and Message Volume as of 12:40 p.m. ET on Aug. 18, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user said they are entering a short position in the stock.<stembedurl>https://stocktwits.com/athebeast/message/625634169</stembedurl>Catheter Precision said it has partnered with HC21, a U.K.-based distributor, to distribute LockeT. Fatih Ayoglu, Sales Manager EMEA and APAC, said that the device’s intuitive design and ease of deployment enable earlier discharge following cardiac procedures.“This directly supports NHS efforts to reduce waiting lists by freeing up hospital capacity and accelerating patient throughput. With the NHS recently achieving its first reduction in waiting lists in 17 years, LockeT is poised to contribute meaningfully to this momentum by helping clinicians deliver more treatments, more efficiently,” Ayoglu added.VTAK stock is down by 56% this year and by about 91% over the past 12 months.&nbsp;Read also: <a href="https://stocktwits.com/news-articles/markets/equity/vanda-pharma-stock-rallies-after-federal-appeals-court-sets-aside-fda-action/chsOi7vRdXQ">Vanda Pharma Stock Rockets 9% After Federal Appeals Court Sets Aside FDA Action: Retail Expects Stock To Cross $5-Mark</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

Why Did Catheter Precision Stock Soar 49% Today?

The company’s product LockeT, which bagged approval in the U.K., had received CE Mark for European approval and distribution in May 2025.

Catheter Precision, Inc. engages in the design, manufacture, and sale of medical devices and technologies for cardiac electrophysiology. It offers the Amigo Remote Catheter System for positioning, manipulation, and stable control of catheters for use by electrophysiologists in the diagnosis and treatment of abnormal heart rhythms. The company was founded by David Jenkins on September 4, 2002 and is headquartered in Fort Mill, SC.

VTAK
Catheter Precision Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest VTAK News

VTAKCatheter Precision Inc.